ALB and coronary artery disorder: Our study had no direct evidence to demonstrate that albumin reduced the risk of cardiovascular incidents in septic patients with CHD through anti-inflammation, anti-apoptosis, and protection of endothelial cells, thus contributing to a lower mortality rate in the albumin therapy group.